Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The next contraceptive revolution.

L E Atkinson, R Lincoln, J D Forrest

    Family Planning Perspectives
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Developing new contraceptive methods requires significant funding. Current options are inadequate, and future innovations like vaccines and male contraceptives need massive investment to overcome limitations in research and development.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    meso-Acetoxymethyl BODIPY dyes for photodynamic therapy: improved photostability of singlet oxygen photosensitizers.

    Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2016
    Same author

    Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.

    Neurology·2009
    Same author

    Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.

    Brain : a journal of neurology·2008
    Same author

    Men transmit MS more often to their children vs women: the Carter effect.

    Neurology·2006
    Same author

    Linkage and association analysis of chromosome 19q13 in multiple sclerosis.

    Neurogenetics·2001
    Same author

    Effects of testosterone replacement in hypogonadal men.

    The Journal of clinical endocrinology and metabolism·2000
    Same journal

    Understanding what works and what doesn't in reducing adolescent sexual risk-taking.

    Family planning perspectives·2002
    Same journal

    Early sexual initiation and subsequent sex-related risks among urban minority youth: the reach for health study.

    Family planning perspectives·2002
    Same journal

    The effects of early childbearing on schooling over time.

    Family planning perspectives·2002
    Same journal

    Socioeconomic disadvantage and adolescent women's sexual and reproductive behavior: the case of five developed countries.

    Family planning perspectives·2002
    Same journal

    Differences in teenage pregnancy rates among five developed countries: the roles of sexual activity and contraceptive use.

    Family planning perspectives·2002
    Same journal

    The IUD and recovery of fertility.

    Family planning perspectives·2001
    See all related articles

    Area of Science:

    • Reproductive Health
    • Medical Research
    • Pharmaceutical Development

    Background:

    • Modern contraceptives have revolutionized family planning globally.
    • Existing methods face challenges including safety concerns, legal issues, and evolving lifestyle needs.
    • Current contraceptive options are insufficient to meet global demand.

    Purpose of the Study:

    • To assess the funding needs for advancing contraceptive research and development.
    • To identify the limitations in current contraceptive R&D and explore future needs.
    • To highlight the necessity for increased investment in novel contraceptive technologies.

    Main Methods:

    • Analysis of current contraceptive research and development (R&D) programs.
    • Estimation of additional annual funding required to accelerate research.

    Related Experiment Videos

  • Evaluation of the role of public-sector R&D organizations and dedicated centers.

    • Main Results:

    • Eight R&D programs account for over half of current contraceptive development.
    • These programs currently spend approximately $30 million annually.
    • An additional $23 million annually could significantly accelerate research and initiate new projects.

    Conclusions:

    • Radically new contraceptive methods, such as vaccines and male contraceptives, require substantial funding increases.
    • The pharmaceutical industry's reduced role necessitates expanded efforts from public-sector R&D.
    • Establishing dedicated R&D centers is crucial for future contraceptive development and introduction.